Rezum therapy, a feasible and safe treatment for the larger prostate
Autor: | Rashed Rowaiee, Aya Akhras, Farhad K. Janahi |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Urinary system Urology Case Report urologic and male genital diseases Minimally invasive treatment 03 medical and health sciences 0302 clinical medicine Quality of life Lower urinary tract symptoms Prostate Rezum medicine Nocturia Transurethral resection of the prostate Benign prostatic hyperplasia urogenital system business.industry Gold standard medicine.disease medicine.anatomical_structure 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Surgery medicine.symptom business Watchful waiting |
Zdroj: | International Journal of Surgery Case Reports |
ISSN: | 2210-2612 |
DOI: | 10.1016/j.ijscr.2021.105871 |
Popis: | Highlights • Rezum is a novel approach to treating BPH symptoms in patients with prostates Benign prostatic hyperplasia (BPH) is the leading cause of Lower Urinary Tract Symptoms (LUTS) in men worldwide. Urinary frequency, nocturia and incomplete emptying are common symptoms experienced by men with BPH, which significantly reduce their quality of life. Treatment for this dysfunction includes surgical and non-surgical modalities such as watchful waiting, lifestyle modification and medication. Historically, Transurethral Resection of the Prostate (TURP) had been considered the gold standard mainstay of treatment; however, in recent years, minimally invasive techniques which offer similar outcomes, fewer complications and cost-effectiveness have gained popularity. Rezum, is a relatively new minimally invasive modality used to treat BPH which has been recommended for prostate volumes of ≤80 cc. Herein, we present a successful case of managing BPH in a middle-aged patient with a prostate volume of 186 cc. |
Databáze: | OpenAIRE |
Externí odkaz: |